Nuveen’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.42M Buy
287,721
+8,268
+3% +$84.6K ﹤0.01% 2053
2025
Q4
$2.78M Buy
279,453
+3,245
+1% +$31K ﹤0.01% 2156
2025
Q3
$2.47M Buy
276,208
+7,390
+3% +$68.4K ﹤0.01% 2217
2025
Q2
$2.53M Sell
268,818
-47,363
-15% -$418K ﹤0.01% 2195
2025
Q1
$3.43M Buy
316,181
+73
+0% +$734 ﹤0.01% 2106
2024
Q4
$3.01M Buy
316,108
+69,050
+28% +$699K ﹤0.01% 2218
2024
Q3
$2.77M Sell
247,058
-90,018
-27% -$957K ﹤0.01% 2265
2024
Q2
$3.37M Buy
337,076
+11,275
+3% +$115K ﹤0.01% 2133
2024
Q1
$3.75M Sell
325,801
-4,550
-1% -$38.6K ﹤0.01% 2121
2023
Q4
$2.41M Buy
330,351
+77,201
+30% +$609K ﹤0.01% 2325
2023
Q3
$2.3M Buy
253,150
+45,948
+22% +$551K ﹤0.01% 2237
2023
Q2
$2.52M Sell
207,202
-68,914
-25% -$768K ﹤0.01% 2245
2023
Q1
$3.43M Sell
276,116
-122,810
-31% -$2.26M ﹤0.01% 2096
2022
Q4
$7.67M Sell
398,926
-238,631
-37% -$5.05M ﹤0.01% 1666
2022
Q3
$12M Buy
637,557
+28,867
+5% +$593K ﹤0.01% 1360
2022
Q2
$11M Buy
608,690
+254,254
+72% +$4.13M ﹤0.01% 1441
2022
Q1
$6.12M Buy
354,436
+947
+0.3% +$17K ﹤0.01% 1950
2021
Q4
$8.65M Buy
353,489
+15,733
+5% +$369K ﹤0.01% 1784
2021
Q3
$7.87M Sell
337,756
-55,138
-14% -$1.33M ﹤0.01% 1954
2021
Q2
$10.8M Buy
392,894
+74,284
+23% +$2.12M ﹤0.01% 1822
2021
Q1
$11.7M Buy
318,610
+213,354
+203% +$7.54M ﹤0.01% 1699
2020
Q4
$3.95M Buy
105,256
+8,151
+8% +$252K ﹤0.01% 2190
2020
Q3
$2.12M Buy
97,105
+84,597
+676% +$1.78M ﹤0.01% 2355
2020
Q2
$201K Buy
+12,508
New +$209K ﹤0.01% 3103

Other funds holding AHCO

Nuveen's AHCO Position: Q1 2026 in Review

Nuveen increased its AdaptHealth (AHCO) stake by 3% in Q1 2026, buying an estimated $84.6K and bringing the position to 287,721 shares worth $3.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2053.

Nuveen first reported a position in AHCO in Q2 2020 and has held it in 24 quarters since. The position peaked at $12M in Q3 2022. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Nuveen held 287,721 shares of AdaptHealth worth $3.42M as of Q1 2026.
  • Nuveen bought 8,268 AdaptHealth shares in Q1 2026, an estimated $84.6K.
  • AdaptHealth made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2053 holding.
  • Nuveen first reported a position in AdaptHealth in Q2 2020 and has held it in 24 quarters since.
  • Nuveen's AdaptHealth position peaked at $12M in Q3 2022.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.